| |
 |
Hypoxia Inducible Factor as a Cancer Drug Target
|
| |
|
pp.391-405 (15) Authors: Sarah J. Welsh, Garth Powis
|
| |
|
|
| |
|
Nitric Oxide-Releasing Non Steroidal Anti-Inflammatory Drugs: A New Generation of Anti-Tumoral Molecules
|
| |
|
pp.407-426 (20) Authors: Christian Lavagna, Piero Del Soldato, Jean-Luc Burgaud, Patrick Rampal
|
| |
|
|
| |
|
Emerging Role of Endoglin (CD105) as a Marker of Angiogenesis with Clinical Potential in Human Malignancies
|
| |
|
pp.427-432 (6) Authors: E. Fonsatti, L. Sigalotti, P. Arslan, M. Altomonte, M. Maio
|
| |
|
|
| |
|
Thomsen-Friedenreich Disaccharide Immunogenicity
|
| |
|
pp.433-443 (11) Authors: Fernando J. Irazoqui, Gustavo A. Nores
|
| |
|
|
| |
|
Metabolic Biomarker and Kinase Drug Target Discovery in Cancer Using Stable Isotope-Based Dynamic Metabolic Profiling (SIDMAP)
|
| |
|
pp.445-453 (9) Authors: Laszlo G. Boros, Daniel J. Brackett, George G. Harrigan
|
| |
|
|
| |
|
Cyclooxygenase Inhibition and Mechanisms of Colorectal Cancer Prevention
|
| |
|
pp.455-463 (9) Author: Timothy A. Chan
|
| |
|
|
